Globally, we are quickly running out of antibiotic solutions to fight both common and high-risk bacterial infections. Bacteria are becoming increasingly resistant to over-used antibiotics, and it is no longer financially viable for pharmaceutical companies to invest in the research and development of new antibiotics. The WHO and UN have prioritized this problem. What does this mean for vulnerable patients, and can prevention help?
Lori Burrows guests on 'The Slow Pandemic Podcast' to discuss. Listen here.
